ROR1 and hematologic disorder: Zilovertamab vedotin is a humanized IgG1 monoclonal antibody directed against ROR1, associated with a proteolytically cleavable linker and the antimicrotubule agent monomethyl auristatin E. The transmembrane protein ROR1 has been found overexpressed in several hematologic malignancies.